Insulin resistance & testosterone

The most common reason for low T is metabolic

A man gets a testosterone result that comes back low, and the conversation jumps to whether he needs replacement. What often goes unasked is why the number is low - and for a large share of men, the answer is sitting on the scale and in their fasting glucose. Insulin resistance and metabolic syndrome are among the most common and most reversible causes of low testosterone in men, and the relationship is bidirectional: the metabolic state lowers testosterone, and low testosterone worsens the metabolic state. The good news buried in that loop is that it cuts both ways - improve the metabolism and testosterone tends to follow. Below, each link in the chain is tagged by how strong the evidence actually is, because some of it is rock-solid mechanism and some of it (does giving testosterone fix the metabolism?) is genuinely mixed.

How insulin resistance lowers testosterone Strong evidence

Two well-established mechanisms run in parallel, and they reinforce each other.

• High insulin suppresses SHBG. Chronically elevated insulin tells the liver to make less sex hormone-binding globulin (SHBG), the protein that carries most of the testosterone in your blood. Lower SHBG means less bound testosterone, and since total testosterone counts both bound and free, total T falls. This is the single most consistent finding in the field: insulin is one of the strongest negative regulators of SHBG, which is exactly why a low SHBG is treated as a marker of insulin resistance in its own right.
• Visceral fat aromatizes testosterone to estradiol. The abdominal fat that comes with insulin resistance isn't inert storage - it's an active endocrine organ, rich in the aromatase enzyme that converts testosterone into estradiol. So testosterone is both made less available and actively burned off into estrogen, and the resulting estrogen feeds back on the brain to dial the axis down further. (This is why estradiol so often runs high in exactly this population.)
• Inflammation suppresses the axis. Visceral fat secretes inflammatory cytokines that blunt the brain's GnRH/LH signal to the testes - the same inflammatory route covered in gut inflammation and testosterone. The net result in metabolic disease is usually a hypogonadotropic pattern: low testosterone with LH that's normal or low rather than high, pointing the problem upstream rather than at the testes.

Pitteloud and colleagues showed the relationship cleanly in men: lower insulin sensitivity tracked with lower testosterone and a blunted Leydig-cell testosterone response, linking the metabolic and gonadal axes directly. And at the population level, the association is among the most replicated in endocrinology - low total testosterone is strongly associated with type 2 diabetes and the metabolic syndrome across large cohorts, in both directions.

The hypogonadal-obesity cycle - why it feeds itself Strong evidence

The mechanisms above don't sit still; they spiral. Excess visceral fat lowers testosterone (via SHBG, aromatase, and inflammation). Lower testosterone, in turn, shifts body composition toward more fat and less muscle and reduces the drive to be active. More fat means more aromatase, more inflammation, and worse insulin sensitivity - which lowers testosterone again. This self-reinforcing spiral is often called the hypogonadal-obesity cycle, and it's the reason metabolic low-T tends to get worse on its own rather than plateauing. Kelly and Jones laid out this loop in detail in their review of testosterone and obesity. The practical implication is that you can't reliably break the cycle by treating one node in isolation - and the node with the most leverage usually isn't the testosterone.

What it does to your panel - and why it hides Strong evidence

This is the practical payoff, and it ties directly to the free-versus-total testosterone problem. Because insulin resistance lowers SHBG, it distorts the panel in a specific, predictable way:

• Total testosterone reads low - dragged down because there's less SHBG to carry the bound fraction.
• Free testosterone is relatively preserved. The active, unbound fraction takes a smaller hit, so calculated free T can look "less bad" than the total suggests.

This is the mirror image of the high-SHBG problem (where total T looks fine but free T is low because too much is bound up). In low-SHBG metabolic men, the danger is the opposite: reading total testosterone alone over-calls the deficiency and can push someone toward replacement when their free (active) testosterone isn't as low as the headline number, and when the real fix is metabolic. The way out is to never read total T in isolation: measure SHBG and calculate free testosterone, and read both alongside the metabolic markers. Our free testosterone calculator does the free-T math from total T, SHBG, and albumin so the distortion is visible rather than hidden.

What reverses it - weight loss and metabolic repair Strong evidence

Here's the encouraging part, and it's well supported. Because the testosterone problem is downstream of the metabolic one, improving the metabolism raises testosterone - often substantially.

• Weight loss raises testosterone, dose-dependently. A meta-analysis by Corona and colleagues found that body-weight loss reverts much of the obesity-associated hypogonadotropic hypogonadism, with the testosterone gain scaling to the amount of weight lost.
• Bariatric surgery raises it the most. Because it produces the largest and most durable weight loss, surgery produces the biggest testosterone increases in the same meta-analyses - a clean demonstration that the hormone tracks the metabolic state.
• Improving glycemic control and activity helps. Reducing visceral fat lowers aromatase and inflammation and restores SHBG toward normal, easing the suppression on the axis from several directions at once.

This is where the GLP-1 medications become relevant: by driving meaningful weight loss and improving insulin sensitivity, they address the upstream cause, and the testosterone improvement is a plausible downstream benefit of that metabolic repair rather than a direct hormonal effect. The framing matters - the lever is the metabolism, and testosterone is the thing that moves when the metabolism does.

Does giving testosterone fix insulin resistance? Mixed evidence

The reverse question - if you simply give a man testosterone, does his insulin resistance or diabetes improve? - has a genuinely mixed answer, and this is where honest framing matters most. Some trials show testosterone modestly improves insulin sensitivity, lean mass, and fat distribution in hypogonadal men. The largest signal comes from the T4DM trial (Wittert and colleagues), where two years of testosterone on top of a lifestyle program reduced progression to type 2 diabetes compared with lifestyle alone. But the effect was modest, it required the lifestyle change alongside it, there were the expected cardiovascular and prostate safety considerations to monitor, and testosterone is not a licensed treatment for diabetes.

So the defensible read is: testosterone replacement may have a role in men who are genuinely hypogonadal, and it can be a useful adjunct, but it is not a substitute for fixing the metabolic problem. The durable lever - the one that addresses the cause and reliably moves both the metabolism and the testosterone - is weight, activity, sleep, and glycemic control. Reaching for testosterone by default treats the symptom and leaves the loop intact. This is the same logic as the broader earn-your-baseline-first thesis, and a reason to read the side effects of replacement before assuming it's the answer.

Signs your low T might be metabolic (and what to test)

None of these are diagnostic on their own - they're patterns that point toward checking the metabolic picture rather than away from it.

The practical panel: read your total + free testosterone with SHBG (so free can be calculated) alongside the metabolic markers - fasting glucose and fasting insulin (to derive HOMA-IR) or HbA1c, a lipid panel, and hs-CRP for the inflammatory overlap. The point isn't to chase a hormone number; it's to see whether the metabolism is the driver before deciding what to do about the testosterone. → the bloodwork guide covers the full panel and lab-day timing, free vs total T explains why SHBG changes the interpretation, and normal labs but still feel low covers the bigger picture of reading a panel as a system.